357 Results (Page 14 of 15)
Vietnam Markets Research Reports
Vietnam Hemodialysis Vascular Grafts Market Analysis
Vietnam Hemodialysis Vascular Grafts Market was valued at $1,050 Mn in 2023 and is predicted to grow at a CAGR of 5.33% from 2023 to 2030, to $1,510 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic kidney disease, the aging population, and technological advancements. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Vietnam MRI Market Analysis
The Vietnam MRI Market was valued at $33.20 Mn in 2023 and is predicted to grow at a CAGR of 6.73% from 2023 to 2030, to $52.38 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, increase healthcare expenditure, and focus on early detection. The key players in the industry are Siemens Healthineers, Neusoft Medical Systems Vietnam, and IBM Watson Health among others.
Vietnam Hypersomnia Therapeutics Market Analysis
The Vietnam Hypersomnia Therapeutics Market was valued at $6.44 Mn in 2023 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $9.68 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are Teva, Jazz Pharmaceuticals, ImexPharma, Sanofi, and Pfizer among others.
Vietnam Dental Implant Market Analysis
Vietnam Dental Implant Market was valued at $24.90 Mn in 2023 and is predicted to grow at a CAGR of 10.03% from 2023 to 2030, to $48.70 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, growing dental awareness, and advanced dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Vietnam Head and Neck Cancer Therapeutics Market Analysis
The Vietnam Head and Neck Cancer Therapeutics Market was valued at $3.42 Mn in 2023 and is predicted to grow at a CAGR of 14% from 2023 to 2030, to $8.55 Mn by 2030. The key drivers of this industry include rising incidence, aging population, and rising disposable income. The industry is primarily dominated by players such as Merck, Pfizer, Novartis, and AstraZeneca among others.
Vietnam PET Scan Market Analysis
The Vietnam PET Scan Market was valued at $9.7 Mn in 2023 and is predicted to grow at a CAGR of 5.63% from 2023 to 2030, to $14.2 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the Vietnam PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.
Vietnam Genomic Diagnostics Market Analysis
Vietnam Genomic Diagnostics Market was valued at $163.25 Mn in 2023 and is predicted to grow at a CAGR of 16.73% from 2023 to 2030, to $482.09 Mn by 2030. The key drivers of this industry include technological advancements, government initiatives, and growing demand for early detection and prevention. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Vietnam Mouth Ulcer Therapeutics Market Analysis
The Vietnam Mouth Ulcer Therapeutics Market was valued at $7.6 Mn in 2023 and is projected to grow at a CAGR of 4.13% from 2023 to 2023, to $10.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Hau Giang Pharmaceuticals, Traphaco, Bristol-Myers Squibb Company, Bayer, Novartis, GlaxoSmithKline PLC, Pfizer, Inc. among others.
Vietnam Compression Therapy Market Analysis
Vietnam Compression Therapy Market was valued at $19 Mn in 2022 and is estimated to reach $30 Mn in 2030, exhibiting a CAGR of 5.83% during the forecast period. The growing prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry comprise firms such as Mölnlycke Health Care, Sigvaris, Medi GmbH & Co., Bauerfeind, BSN Medical, Hartmann Group, GC Medical Supply Co., Juzo, McKesson, and Cardinal Health.
Vietnam Bariatric Surgery Devices Market Analysis
The Vietnam Bariatric Surgery Devices Market was valued at $13.3 Mn in 2023 and is projected to grow at a CAGR of 5.43% from 2023 to 2023, to $19.3 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Vietnam CT Scan Market Analysis
Vietnam CT Scan Market was valued at $23.05 Mn in 2023 and is predicted to grow at a CAGR of 8.1% from 2023 to 2030, to $39.76 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, increasing healthcare expenditure, an aging population, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Vietnam Lipid Disorder Therapeutics Market Analysis
The Vietnam Lipid Disorder Therapeutics Market was valued at $28.3 Mn in 2023 and is predicted to grow at a CAGR of 14.13% from 2023 to 2030, to $71.3 Mn by 2030. Vietnam Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Non-Communicable Diseases, Growing Awareness and Focus on Chronic Disease Management, and Increasing Healthcare Expenditure. The industry is primarily dominated by players such as Boehringer Ingelheim, Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Vietnam Bio-Implant Market Analysis
The Vietnam Bio-implant Market was valued at $325 Mn in 2023 and is predicted to grow at a CAGR of 6.13% from 2023 to 2030, to 492.9 Mn by 2030. The Vietnam Bio-implant Market is growing due to like Increasing Disposable Income and Health Awareness, Growing Aging Population, Government Initiatives and Support. The market is primarily dominated by players such as Orthopaedic International, OrthoMed, Medline Vietnam, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Vietnam Mental Health Apps Market Analysis
The Vietnam Mental Health Apps Market was valued at $31 Mn in 2023 and is predicted to grow at a CAGR of 15.43% from 2023 to 2030, to $84.64 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, rising awareness, and rising interest in preventive care. The industry is primarily dominated by players such as Calm, Happify, Headspace, and Wysa among others.
Vietnam Actinic Keratosis Therapeutic Market Analysis
The Vietnam Actinic Keratosis Therapeutic Market is expected to grow at a CAGR of 5.13% during the forecast period, rising from $34 Mn in the year 2022 and reaching $51 Mn by the year 2030. The Vietnam Actinic Keratosis Market is driven by factors like the introduction of new products, a focus on market penetration in developing regions, and the rising demand and acceptance of minimally invasive procedures. Key players in the Vietnam Actinic Keratosis Therapeutic Market include global market players like LEO Pharma, Galderma, Sun Pharmaceuticals, Bayer, Alma Lasers, Syneron Candela, and some domestic players like Vinpharmex and Traphaco
Vietnam Constipation Therapeutics Market Analysis
Vietnam Constipation Therapeutics Market was valued at $91 Mn in 2022 and is estimated to reach $153 Mn in 2030, exhibiting a CAGR of 6.73% during the forecast period. The global growth of the constipation therapeutics market is driven by factors such as aging, sedentary lifestyles, and unhealthy dietary habits. The increasing elderly population, susceptible to chronic conditions, notably contributes to this expansion. Major players in this sector comprise GlaxoSmithKline, Johnson & Johnson, Sanofi, Abbott, Bayer, AstraZeneca, Pfizer, Merck Sharp & Dohme, Boehringer Ingelheim, and United Laboratories.
Vietnam Herbal Supplements Market Report
The Vietnam Herbal Supplements Market was valued at $26.30 Mn in 2023 and is predicted to grow at a CAGR of 6.43% from 2023 to 2030, to $40.68 Mn by 2030. The key drivers of this industry include increased awareness, rising disposable income, and expansion of distribution channels. The industry is primarily dominated by players such as Himalaya, Herbalife Nutrition, Patanjali Ayurved, and Sao Thai Duong Company among others.
Vietnam Brugada Syndrome Market Analysis
The Vietnam Brugada Syndrome Market was valued at $6 Mn in 2023 and is predicted to grow at a CAGR of 10.3% from 2023 to 2030, to $12.2 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, geriatric population, and advancements in genetic testing. The prominent players of the Vietnam Brugada Syndrome Market are Nipro Pharma, Sanofi, StellaPharm, Vimedimex, Medtronic, and GSK, among others.
Vietnam Blood Disorder Therapeutics Market
Vietnam Blood Disorder Therapeutics Market valued at $67 Mn in 2022, projected to reach $122 Mn by 2030 with a 7.73% CAGR. The key drivers of the market in Vietnam include the increasing prevalence of diseases such as aplastic anemia, hemophilia, and thalassemia due to advancements in diagnostics, lifestyle changes, and genetic susceptibility, supported by government initiatives prioritizing healthcare improvement in the country. The Vietnam Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Sanofi, Novo Nordisk, CSL Ltd, Pfizer, Bayer, Sun Pharma, Teva, Ha Tay Pharma, Imexpharm, etc, among various others.
Vietnam Dental Endodontics Market Analysis
Vietnam Dental Endodontics Market was valued at $8.80 Mn in 2023 and is predicted to grow at a CAGR of 4.53% from 2023 to 2030, to $11.90 Mn by 2030. The key drivers of this industry include increasing awareness of oral health, the rising prevalence of dental problems, and growing dental infrastructure. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Vietnam Cancer Induced Bone Disease Therapeutics Market
Vietnam Cancer Induced Bone Disease Therapeutics Market valued at $7 Mn in 2022, projected to reach $10 Mn by 2030 with a 6.03% CAGR. The key drivers of this industry include the rising incidence of cancer, the expanding treatment landscape, and increased government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, AstraZeneca, Merck, Eli Lilly, Pfizer, Johnson & Johnson, Amgen, and Novartis among others.
Vietnam Clinical Nutrition Market Analysis
The Vietnam Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 5.57% from 2023 to 2023, to $224.1 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Danone Nutrition, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc Ltd, Mead Johnson & Company, LLC among others.
Vietnam Breast Pump Market Report
The Vietnam Breast Pump Market was valued at $14.7 Mn in 2023 and is predicted to grow at a CAGR of 8.83% from 2023 to 2030, to $26.6 Mn by 2030. The key drivers of the market include the rising female workforce, enhanced features, and consumer awareness. The prominent players in the Vietnam Breast Pump Market are Asia Connection, Pigeon, Playtex, Ameda, Avent, and Evenflo, among others.
Vietnam Cardiac Resynchronization Therapy Market
Vietnam Cardiac Resynchronization Therapy Market valued at $24 Mn in 2022, projected to reach $36 Mn by 2030 with a 5.23% CAGR. The notable increase in heart failure cases worldwide, propelled by aging demographics and lifestyle-associated cardiovascular ailments, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.
Vietnam Digital Biomarkers Market Analysis
Vietnam Digital Biomarkers Market was valued at $14.50 Mn in 2023 and is predicted to grow at a CAGR of 22.53% from 2023 to 2030, to $60.13 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, growing focus on preventative care, and the aging population. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.